STD Treatments
Mfg : ChartwellDoxy PEP 100 MG
Morning After STD Prevention Pill Doxy PEP 100 mg is a prescription antibiotic taken after sex to prevent bacterial STIs including chlamydia, syphilis, and gonorrhea.
For High-Risk Individuals Recommended for MSM, transgender women, and those with recent STI history or multiple partners [citation:1][citation:9]
Take Within 72 Hours Two 100 mg tablets taken as soon as possible, ideally within 24 hours and no later than 72 hours after sex [citation:1][citation:2][citation:6]
Proven Effectiveness Reduces chlamydia and syphilis by >70% and gonorrhea by approximately 50% [citation:1][citation:3][citation:10]
Prescription & Monitoring Required Requires medical evaluation, regular STI testing every 3-6 months, and ongoing provider assessment [citation:1][citation:3]
Maximum Doses: 4
Per Dose $ 00.00
Total Price
This page provides information for Doxy PEP (doxycycline hyclate) 100 mg tablets. Doxy PEP is a prescription antibiotic used as post-exposure prophylaxis to prevent bacterial sexually transmitted infections (STIs) after sexual activity. The information provided is for educational purposes only and does not replace professional medical advice.
This is a prescription medication. It is not available over-the-counter. A licensed healthcare provider must evaluate your medical history, risk factors, and current health status to determine if Doxy PEP is appropriate for you. Do not use this medication without a valid prescription and proper medical supervision [citation:9].
Doxy PEP stands for Doxycycline Post-Exposure Prophylaxis. It is a novel, patient-managed biomedical STI prevention strategy recommended by the CDC for individuals at higher risk of bacterial STIs [citation:1][citation:3]. Unlike HIV PrEP (taken before exposure), Doxy PEP is taken after sex to prevent infections from taking hold [citation:2].
CDC guidelines recommend Doxy PEP for individuals who are at higher risk of bacterial STIs, including [citation:1][citation:9]:
Additional populations who may benefit include [citation:1]:
Note: Current evidence does not support the use of Doxy PEP in cisgender women, as clinical trials did not demonstrate effectiveness in this population, likely due to adherence issues [citation:7].
Based on CDC guidelines and clinical trial data [citation:1][citation:2][citation:6]:
Clinical trials have demonstrated that Doxy PEP significantly reduces the risk of [citation:1][citation:3][citation:10]:
Doxy PEP does NOT prevent [citation:2][citation:10]:
Persons prescribed Doxy PEP should undergo bacterial STI testing at anatomic sites of exposure at baseline and every 3-6 months thereafter. Ongoing need for Doxy PEP should be assessed every 3-6 months as well [citation:1][citation:3]. HIV screening should also be performed according to current recommendations [citation:1].